[225Ac]Ac-PSMA-617 mutational landscape in circulating tumor DNA (ctDNA): early clinical outcome prediction in metastatic castration-resistant prostate cancer

被引：0
|
作者：
Amghar, M. [1 ]
Rausch, T. [2 ]
Hielscher, T. [1 ]
Ozgur, H. [2 ]
Roscher, M. [1 ]
Bauder-Wuest, U. [1 ]
Schick, M. [1 ]
Remde, Y. [1 ]
Bakos, G. [1 ]
Schaefer, M. [1 ]
Bruchertseifer, F. [3 ]
Morgenstern, A. [3 ]
Benes, V. [2 ]
Kratochwil, C. [4 ]
Benesova-Schaefer, M. [1 ]
机构：
[1] DKFZ, Heidelberg, Germany
[2] EMBL, Heidelberg, Germany
[3] Joint Res Ctr JRC, European Commiss, Karlsruhe, Germany
[4] Univ Hosp, Dept Nucl Med, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-719
引用
收藏
页码：S326 / S326
页数：1
相关论文
共 50 条
  • [31] Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy
    Sathekge, Mike
    Bruchertseifer, Frank
    Vorster, Mariza
    Lawal, Ismaheel O.
    Knoesen, Otto
    Mahapane, Johncy
    Davis, Cindy
    Reyneke, Florette
    Maes, Alex
    Kratochwil, Clemens
    Lengana, Thabo
    Giesel, Frederik L.
    Van de Wiele, Christophe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 62 - 69
  • [32] Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results
    Yadav, Madhav
    Ballal, Sanjana
    Bal, Chandrasekhar
    Tripathi, Madhavi
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [33] Efficacy and Safety of 225Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Ma, Jiao
    Li, Lanying
    Liao, Taiping
    Gong, Weidong
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Bromodomain inhibition potentiates the therapeutic effect of 225Ac-PSMA in Castration-Resistant Prostate Cancer
    Idrissou, Malick Bio
    Carston, Amanda
    Thickens, Anna
    Guevara, Yadira Medina
    Kwon, Ohyun
    Rojas, Hansel Hansel
    Lambert, Liudmila
    Pinchuk, Anatoly
    Bednarz, Bryan
    Iyer, Gopal
    Hernandez, Reinier
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [35] Safety and efficacy of Ac-225-PSMA-617 in metastatic castration resistant prostate cancer (mCRPC) after failure of Lu-177-PSMA
    Tauber, R. L.
    Feuerecker, B.
    Knorr, K.
    Beheshti, A.
    Seidl, C.
    D'Alessandria, C.
    Bruchertseifer, F.
    Retz, M.
    Gschwend, J. E.
    Weber, W.
    Morgenstern, A.
    Eiber, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Clinical-Prostate cancer Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
    van der Doelen, Maarten J.
    Mehra, Niven
    van Oort, Inge M.
    Looijen-Salamon, Monika G.
    Janssen, Marcel J. R.
    Custers, Jose A. E.
    Slootbeek, Peter H. J.
    Kroeze, Leonie, I
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Haberkorn, Uwe
    Kratochwil, Clemens
    Nagarajah, James
    Gerritsen, Winald R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 729.e7 - 729.e16
  • [37] Circulating Tumor DNA (ctDNA) Testing in TALAPRO-2 Complements Tumor Testing to Gain a Greater Understanding of the Metastatic Castration-Resistant Prostate Cancer (mCRPC) Mutational Landscape
    Yip, S.
    Laird, D.
    Azad, A.
    Zschabitz, S.
    Fizazi, K.
    Matsubara, N.
    Joung, J.
    Karsh, L.
    Carles, J.
    Fay, A.
    Piulats, J.
    Fong, P.
    Liu, G.
    Albacker, L.
    Pasquina, L.
    Chelliserry, J.
    Healy, C.
    Lin, X.
    Kalac, M.
    Agarwal, N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S107 - S107
  • [38] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Therapeutic efficacy and clinical outcome of 177Lu-PSMA-617/225Ac-PSMA-617 radioligand therapy in metastatic castration resistant prostate cancer (mCRPC) - single institutional experience from India
    Kalra, Kriti
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [40] 225Ac-PSMA-617 treatment and follow up in advanced stage metastatic castration resistant prostate cancer: First clinical experience from Azerbaijan
    Novruzov, F.
    Aliyev, J.
    Guliyev, F.
    Abbasov, B.
    Mehmetbeyli, L.
    Mehdi, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S650 - S650
12345